Canaccord Genuity analyst Kyle Rose raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $26.00 (from $22.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

AxoGen, Inc. (AXGN) PT Raised to $25 at Raymond JamesFebruary 25, 2025 4:00 PM AxoGen, Inc. (AXGN) PT Raised to $25 at Leerink PartnersFebruary 25, 2025 1:07 PM AxoGen, Inc. (AXGN) PT Raised to $24 at Cantor FitzgeraldFebruary 25, 2025 10:41 AM AxoGen (AXGN) Tops Q4 EPS by 4cFebruary 25, 2025 7:16 AM Form 8-K Axogen, Inc. For: Feb 25February 25, 2025 7:10 AM Axogen, Inc. To Host Analyst & Investor Day on March 4thFebruary 25, 2025 7:10 AM